Detection of prediabetes and undiagnosed type 2 diabetes in underserved communities using community pharmacy point‐of‐care testing: A prospective feasibility study
Authors' conclusion
Community pharmacies provided effective, equitable access to HbA1c testing and diabetes prevention, identifying individuals with prediabetes and undiagnosed T2D being missed by current pathways and doubling engagement of this underserved population with DPP.
Study context
- Population
- Adults at high risk of T2D (Diabetes UK 'Know Your Risk' tool), 16 community pharmacies in NHS Tayside, Scotland, Feb 2024-Jan 2025499 pharmacy participants
- Participants
- 499 vs 951
- Exposure
- Pharmacy-based point-of-care HbA1c testing vs GP-identified recruitment to DPP
- Pharmacyn = 499
- GPn = 951reference
- Outcome
- Detection of prediabetes and undiagnosed T2D (pharmacy)
Methodological detailsmulticentre, 16 community pharmacies
- Multicentre
- 16 community pharmacies
Main finding
As reported in the abstract
Prediabetes (HbA1c 42-47 mmol/mol)
75
15%
HbA1c ≥48 mmol/mol (6.5%)
19
4%
Observational data: associations, not effects.
Further findings
| Outcome | Pharmacy | GP | RR (95% CI) | |
|---|---|---|---|---|
| Enrolment in DPP among those with prediabetes | 51% | 32% | 2.08 (1.61–2.67) | |
| 0.20.5125Relative risk (log scale) |
Deprivation (SIMD 1-2)
Attended GP among those with HbA1c ≥48 mmol/mol
- Attended GP
- 17
Deprivation (SIMD 1-2)
- Pharmacy recruited relatively younger participants from more deprived backgrounds
Original publication
Detection of prediabetes and undiagnosed type 2 diabetes in underserved communities using community pharmacy point‐of‐care testing: A prospective feasibility study. Diabet Med. Published 15 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →